Advancing Prime Minister Narendra Modi’s vision of “Viksit Bharat” through Indian-led innovation in longevity, AI, and preventive health research.
Imagine a world where aging isn’t about slowing down, but about maintaining your vitality, strength, and sharpness well into your 80s and beyond. This isn’t just a dream—it’s the next frontier of science, and India is right at the helm.
In a defining moment for India’s scientific and digital-health ecosystem, GOQii’s Sanjeevini Project has been selected as one of the Top 40 semifinalists in the global $101 million XPRIZE Healthspan competition. This prestigious recognition positions our nation at the forefront of global longevity and healthy-aging research.
This achievement aligns perfectly with Prime Minister Narendra Modi’s vision of “Viksit Bharat 2047” and “Atmanirbhar Bharat”, showcasing how Indian R&D, clinical excellence, and digital innovation can shape the global future of health and longevity.
The Sanjeevini Program: An Operating System for a New Biological Future
Led by GOQii, the Sanjeevini initiative represents India’s most comprehensive and data-driven effort to extend human vitality. But Sanjeevini is not merely a study—it is the Operating System for a New Biological Future.
Powered by the proprietary A.L.I.V.E OS framework (Artificial Life Intelligence for Vitality Enhancement), Sanjeevini combines the power of:
- Genomics & Microbiome Analytics
- Real-time Biosensing
- Neuroadaptive AI Systems
The goal? To rejuvenate biological processes, enhance vitality, and extend healthspan.
For participants aged 50–80, this means receiving deeply personalized nutrition, exercise, cognitive training, and supplementation plans directly through the GOQii platform. With AI-driven coaching, gamification, and community engagement, the program transforms complex longevity science into an accessible, measurable, and engaging lifestyle system.
Strength in Collaboration: A Unified Indian Consortium
The success of Sanjeevini is built on a powerful alliance of India’s leading institutions, experts, and innovators across science, medicine, and technology. This multidisciplinary consortium defines a new Indian model for translational longevity research.
- Ashoka University (Trivedi School of Biosciences): Scientific leadership and study design.
- Koita Centre for Digital Health (IIT Bombay): Advanced AI, analytics, and data modeling.
- Tata 1mg: Nationwide diagnostic infrastructure and precision testing.
- Decode Age: Advanced microbiome and longevity biomarker analytics.
- Acrannolife Genomics: Patented cfDNA and molecular aging diagnostics.
- NIMS, Jaipur: Clinical investigation site and medical supervisor.
- Khayaal and GenWise: Partners for community engagement and social well-being for older adults.
Voices of the Consortium
Our partners are united by a single mission: to make healthy aging a measurable reality. Here is what the leaders of this initiative have to say:
“India has the talent, data, and determination to lead the next frontier of longevity science. Through the A.L.I.V.E OS framework, Sanjeevini brings together AI, genomics, and lifestyle intelligence to make vitality a measurable, achievable reality.” – Vishal Gondal, Founder & CEO, GOQii
“The future of aging is deeply personal, but powered by data. Sanjeevini fuses biological insight with behavioral intelligence, creating a system of continuous, adaptive care.” – Professor Anurag Agrawal, Dean, Trivedi School of Biosciences, Ashoka University
“Wearable sensor technology and advanced algorithms are revolutionizing preventive medicine. At Sanjeevini, we combine these innovations with cell-free DNA analytics to pioneer biological age management—we don’t just measure biological age, we actively influence it.” – Dr. Nirmal Punjabi, Koita Centre for Digital Health, IIT Bombay
“Tata 1mg is excited to contribute our diagnostic and lab expertise to the Sanjeevini initiative. We will provide comprehensive, reliable testing services – from blood work to genetic markers – to ensure that every participant’s plan is truly personalized.” – Prashant Tandon, CEO, Tata 1mg
“We’ve always believed prevention must go beyond advice. Sanjeevini delivers this belief through real-time personalization and measurable transformation.” – Luke Coutinho, Integrative Health Expert and Advisor to GOQii
“Most people accept ageing as fate, but we see it as a design. By supporting the Sanjeevini initiative in the XPRIZE healthspan challenge, Decode Age aims to show that healthspan can be built, measured and improved.” – Parth Amin, CEO, Decode Age
“Cell-free DNA offers an unprecedented window into the body’s biological aging process. Through our collaboration with GOQii Team Sanjeevini, we’re turning these insights into timely, personalized care.” – Avinash Ramani, Founder, Acrannolife Genomics
“This platform redefines scalable, outcomes-based care. It integrates precision diagnostics with behavior change in a way that has the potential to transform how global health systems manage aging populations.” – Amit Mookim, CEO, Immuneel Therapeutics & Strategic Advisor
The Next Frontier: Clinical Validation
GOQii Sanjeevini has now entered its first critical phase—a 60-day randomized controlled clinical trial (RCT).
- Participants: 40 individuals aged 50–80.
- Locations: 3 centers across Jaipur, Delhi, and Mumbai.
- Goal: To assess measurable improvements in immunity, cognition, muscle strength, and biological age.
The trial has obtained Ethics Committee approval and follows strict Good Clinical Practice (GCP) guidelines. The results will pave the way for a larger multi-site expansion planned for 2027–28, aiming to validate the A.L.I.V.E OS framework at a population scale.
India’s Global Leadership in Longevity Science
As longevity becomes the next trillion-dollar frontier, GOQii Sanjeevini cements India’s position as a global center for AI-driven, data-validated healthspan research. It embodies the transition from “Make in India” to “Research in India, for the World,” built on a foundation of ethics, evidence, and compassionate innovation.
GOQii Sanjeevini is India’s blueprint for the future—where artificial intelligence, genomics, and human ingenuity unite to unlock a longer, healthier, and more vibrant life for everyone.
Stay tuned to our blog for more updates on our journey to the XPRIZE finals!
To learn more about how GOQii is revolutionizing preventive health, explore our ecosystem or subscribe to GOQii’s Personalised Health Coaching here.
#BeTheForce
Rita, a 22-year-old student, loves to snack – especially on quick, tasty, and readily available junk food. Over time, she gained excess weight. But what bothered her more was how constantly tired and dull she felt. A routine health check-up revealed nutrient deficiencies – something she found hard to believe. After all, she was eating enough… wasn’t she?
For the first time in human history, living to 90 or even 100 is no longer a rare feat—it’s becoming the norm. But behind this celebration of longer life lies a sobering truth: we’re living longer, but not necessarily better.
Receiving an organ transplant is often described as a second chance at life. But what happens after the surgery is just as crucial as the procedure itself. The journey doesn’t end in the operating room; it begins there.

